Dashboard
Manage Tickers

LQDA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Court Finds United Therapeutics' Interfere...
09/16/2024 13:43:32

Liquidia Corporation (NASDAQ:LQDA) (Liquidia), a biopharmaceutical company developing innovative therapies for patients with ra...

nasdaq-surges-over-200-points-us-crude-oil-stocks-increase
Nasdaq Surges Over 200 Points; US Crude Oi...
09/11/2024 18:30:28

Core News & Articles
Petco, AppLovin, Dave & Buster's And Other...
09/11/2024 14:19:58

liquidia-announces-raise-of-675m-from-new-common-stock-financings-from-the-sale-of-6460674-shares-of-common-stock-at-a-price-of-890-per-share-and-325m-advance-from-healthcare-royalty-under-current-financing-agreement
Liquidia Announces Raise Of $67.5M From Ne...
09/11/2024 12:29:56

Liquidia Corporation (NASDAQ:LQDA) (the "Company" or "Liquidia"), a biopharmaceutical company developing innova...

hc-wainwright--co-reiterates-buy-on-liquidia-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Liqu...
08/23/2024 11:17:43

HC Wainwright & Co. analyst Andrew Fein reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $29 price target.

needham-reiterates-buy-on-liquidia-maintains-19-price-target
Needham Reiterates Buy on Liquidia, Mainta...
08/22/2024 16:02:31

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $19 price target.

liquidia-has-filed-litigation-in-the-us-district-court-of-the-district-of-columbia-that-challenges-the-recent-fda-decision-to-grant-3-year-new-clinical-investigation-exclusivity-nci-exclusivity-to-tyvaso-dpi
Liquidia Has Filed Litigation In The U.S. ...
08/22/2024 10:05:32

FDA granted tentative approval of YUTREPIA (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH) and ...

jim-cramer-praises-paypal-ceo-alex-chriss-financial-techs-have-come-back-in-style
Jim Cramer Praises PayPal CEO Alex Chriss:...
08/21/2024 13:23:11

PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more.

these-analysts-cut-their-forecasts-on-liquidia
These Analysts Cut Their Forecasts On Liqu...
08/20/2024 12:15:20

palo-alto-networks-to-rally-more-than-16-here-are-10-top-analyst-forecasts-for-tuesday
Palo Alto Networks To Rally More Than 16%?...
08/20/2024 11:53:39

btig-maintains-buy-on-liquidia-lowers-price-target-to-25
BTIG Maintains Buy on Liquidia, Lowers Pri...
08/20/2024 11:47:32

BTIG analyst Julian Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $29 to $25.

b-of-a-securities-maintains-buy-on-liquidia-lowers-price-target-to-23
B of A Securities Maintains Buy on Liquidi...
08/20/2024 11:29:07

B of A Securities analyst Greg Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $24 to ...

hc-wainwright--co-maintains-buy-on-liquidia-lowers-price-target-to-29
HC Wainwright & Co. Maintains Buy on Liqui...
08/20/2024 10:48:24

HC Wainwright & Co. analyst Andrew Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $32...

nasdaq-surges-150-points-sonder-holdings-shares-surge
Nasdaq Surges 150 Points; Sonder Holdings ...
08/19/2024 18:37:19

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

btig-maintains-buy-on-liquidia-lowers-price-target-to-25
BTIG Maintains Buy on Liquidia, Lowers Pri...
08/19/2024 17:31:14

BTIG analyst Julian Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $29 to $25.

raymond-james-upgrades-liquidia-to-strong-buy-maintains-price-target-to-27
Raymond James Upgrades Liquidia to Strong ...
08/19/2024 16:52:03

Raymond James analyst Ryan Deschner upgrades Liquidia (NASDAQ:LQDA) from Outperform to Strong Buy and maintains the price ta...

crude-oil-down-2-alzamend-neuro-shares-spike-higher
Crude Oil Down 2%; Alzamend Neuro Shares S...
08/19/2024 16:28:18

dow-jumps-over-100-points-estee-lauder-shares-edge-lower-after-q4-results
Dow Jumps Over 100 Points; Estee Lauder Sh...
08/19/2024 13:56:10

Core News & Articles
Market-Moving News for August 19th
08/19/2024 12:36:45

ALZN: 248% | Alzamend Neuro Partners With Massachusetts General Hospital For First-of-Its-Kind Phase II Study Of AL001 For PTSD...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION